Please login to the form below

Not currently logged in
Email:
Password:

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG).

Provided by Guidelines, it also features: NICE clinical guidelines, NICE quality standards, NICE evidence updates, NICE evidence summaries, independent professional body guidelines and (Scottish Intercollegiate Guidelines Network (SIGN) guidance.

Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare)

September 2018: Independent professional body guideline

Asthma (update)

September 2018: NICE Quality Standard

Depression in adults (update)

September 2018: NICE Quality Standard

Eating disorders

September 2018: NICE Quality Standard

Ovarian cancer (refresh)

September 2018: SIGN guidance

Renal replacement therapy

October 2018: NICE Clinical Guideline

Decision making and mental capacity

October 2018: NICE Social Care Guidance

Foetal alcohol spectrum disorder (update)

October 2018: SIGN guidance

Abdominal aortic aneurysm: diagnosis and management

November 2018: NICE Clinical Guideline

Contraceptive choices for women who are obese/overweight

November 2018: Independent professional body guideline

Visit the Guidelines website

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation 18 Mar 2019
However, even in these cases NICE started off with a draft appraisal rejecting the drugs as not cost effective. ... For its part, Vertex has counter-claimed that NICE's process and NHS England have been inflexible.

NICE partially clears Darzalex combo in blood cancer

NICE partially clears Darzalex combo in blood cancer 13 Mar 2019
limited,” said Meindert Boysen, director of NICE’s Centre for Health Technology Evaluation. ... It’s a familiar decision for Janssen, which last year failed to win over NICE for Darzalex to be used as a third-line treatment in those with multiple

NICE knocks back BioMarin’s Batten disease drug

NICE knocks back BioMarin’s Batten disease drug 22 Feb 2019
treatment at a level that would have addressed the problems highlighted during NICE’s assessment. ... Once these elements are excluded, the cost-effectiveness estimates for cerliponase alfa are far higher than NICE normally considers acceptable for

‘Inflexible’ NICE blocking access to rare disease drugs

‘Inflexible’ NICE blocking access to rare disease drugs 19 Feb 2019
NICE is set to begin reviewing all new medicines reaching the market, and MAP say this make it essential for it to review its rare disease methodology. ... It recommends that NICE adopts five ‘flexibilities’, including different data requirements and

Novartis first to benefit from NICE advice on ‘patient preference’

Novartis first to benefit from NICE advice on ‘patient preference’ 14 Feb 2019
Faced with a budget shortfall, NICE is introducing new fees for life science companies submitting products for appraisal from April.. ... making. NICE makes it clear, however, that paying for scientific advice has no bearing on technology appraisals, and

More news from PMLiVE on NICE, the SMC and the AWMSG

MGP’s Guidelines brand is trusted by over 58,000 healthcare professionals for concise clinical summaries of major primary and shared care guidelines in the UK. Through Guidelines, Guidelines for Nurses and Guidelines in Practice, MGP connect pharmaceutical and medical device companies to an engaged audience of GPs, GP commissioners and payers, nurses and allied healthcare professionals.

To discuss how we can support your guidance or implementation needs please contact marketing@mgp.co.uk

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Infographics